Vera Therapeutics

(NASDAQ) VERA

Current Price$36.63

Market Cap$2.63B

Since IPO (2021)+218%

5 YearN/A

1 Year+69%

1 Month-19%

Vera Therapeutics Financials at a Glance

Market Cap

$2.63B

Revenue (TTM)

$0.00

Net Income (TTM)

$368.95M

EPS (TTM)

$-5.55

P/E Ratio

-6.60

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$36.63

Volume

39,689

Open

$36.87

Price

$36.63

Volume

39,689

Open

$36.87

Previous Close

$36.63

Daily Range

$36.25 - $38.91

52-Week Range

$18.76 - $56.05

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$36.63

Volume

39,689

Open

$36.87

Previous Close

$36.63

Daily Range

$36.25 - $38.91

52-Week Range

$18.76 - $56.05

VERA News

This $91 Million Position Signals Conviction in a Biotech Stock Eyeing FDA Decision This Year

Jonathan PoncianoMar 20, 2026

This Biotech Stock Surged 75% Last Quarter and Pulled a New $9 Million Investment

Jonathan PoncianoMar 16, 2026

This Fund Bet $200 Million on a Biotech Stock Up 50% as Kidney Disease Drug Targets July 7 FDA Decision

Jonathan PoncianoMar 13, 2026

Healthcare professional inspecting charts

Page 1

VERA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Vera Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

339

CEO

Marshall W. Fordyce, MD

Website

www.veratx.com

Headquarters

Brisbane, CA 94005, US

VERA Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-71%

Return on Capital

-66%

Return on Assets

-59%

Earnings Yield

-15.15%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.63B

Shares Outstanding

71.78M

Volume

39.69K

Avg. Volume

1.20M

Financials (TTM)

Gross Profit

$0.00

Operating Income

$315.47M

EBITDA

$291.62M

Operating Cash Flow

$241.10M

Capital Expenditure

$630.00K

Free Cash Flow

$241.73M

Cash & ST Invst.

$714.59M

Total Debt

$77.31M

Vera Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$256.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$2.63B

N/A

Market Cap/Employee

$17.29M

N/A

Employees

152

N/A

Net Income

$121.03M

-134.1%

EBITDA

$125.13M

-151.2%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$521.73M

-2.5%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$75.03M

+40.8%

Short Term Debt

$0.00

-100.0%

Return on Assets

-59.34%

N/A

Return on Invested Capital

-66.50%

N/A

Free Cash Flow

$106.67M

-95.4%

Operating Cash Flow

$106.50M

-95.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CLDXCelldex Therapeutics, Inc.

CLDXCelldex Therapeutics, Inc.$32.28-4.97%

IMNMImmunome, Inc.

IMNMImmunome, Inc.$23.00+2.50%

PHVSPharvaris N.V.

PHVSPharvaris N.V.$29.95-0.47%

HRMYHarmony Biosciences Holdings, Inc.

HRMYHarmony Biosciences Holdings, Inc.$30.18-2.61%

QUREuniQure N.V.

QUREuniQure N.V.$27.64-0.07%

NUVBNuvation Bio Inc.

NUVBNuvation Bio Inc.$4.76-0.63%

ABCLAbCellera Biologics Inc.

ABCLAbCellera Biologics Inc.$5.25+0.19%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$129.44+0.04%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$16.84+0.08%

NOKNokia

NOKNokia$13.92+0.09%

POETPoet Technologies

POETPoet Technologies$13.90+0.27%

SOFISoFi Technologies

SOFISoFi Technologies$16.26+0.03%

ACHRArcher Aviation

ACHRArcher Aviation$6.54+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.96+0.01%

Questions About VERA

What is the current price of Vera Therapeutics?

Vera Therapeutics is trading at $36.63 per share.

What is the 52-week range for Vera Therapeutics?

Over the past 52 weeks, Vera Therapeutics has traded between $18.76 and $56.05.

How much debt does Vera Therapeutics have?

As of the most recent reporting period, Vera Therapeutics reported total debt of $75.03M.

How much cash does Vera Therapeutics have on hand?

Vera Therapeutics reported $114.35M in cash and cash equivalents in its most recent financial results.

What is Vera Therapeutics’s dividend yield?

Vera Therapeutics does not currently have a dividend yield.

Vera Therapeutics

Vera Therapeutics Financials at a Glance

VERA News

This $91 Million Position Signals Conviction in a Biotech Stock Eyeing FDA Decision This Year

This Biotech Stock Surged 75% Last Quarter and Pulled a New $9 Million Investment

This Fund Bet $200 Million on a Biotech Stock Up 50% as Kidney Disease Drug Targets July 7 FDA Decision

Why Vera Therapeutics Stock Zoomed Higher Today

Why Vera Therapeutics Stock Rocked the Market on Tuesday

Why Vera Therapeutics Stock Crushed it Today

Vera (VERA) Q2 Net Loss Widens 127%

Could This Stock Be the Next Biotech Buyout?

VERA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Vera Therapeutics

VERA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Vera Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About VERA

What is the current price of Vera Therapeutics?

What is the 52-week range for Vera Therapeutics?

How much debt does Vera Therapeutics have?

How much cash does Vera Therapeutics have on hand?

What is Vera Therapeutics’s dividend yield?

Premium Investing Services